Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - OPERATING INCOME
Operating Income ABUS - Arbutus Biopharma Corporation
-78.1 M
LAST VALUE
-3.07%
2 YEAR CAGR
2.75%
5 YEAR CAGR
-20.45%
10 YEAR CAGR